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Abstract
Background: Gout is a consequence of an innate immune reaction to monosodium urate crystals deposited in
joints. Acute gout attacks can be triggered by dietary factors that are themselves associated with serum urate levels.
Tomato consumption is an anecdotal trigger of gout flares. This study aimed to measure the frequency of tomato
consumption as a self-reported trigger of gout attacks in a large New Zealand sample set, and to test the hypothesis
that tomato consumption is associated with serum urate levels.
Methods: Two thousand fifty one New Zealanders (of Māori, Pacific Island, European or other ancestry) with
clinically-ascertained gout were asked about gout trigger foods. European individuals from the Atherosclerosis Risk In
Communities (ARIC; n = 7517) Study, Cardiovascular Health Study (CHS; n = 2151) and Framingham Heart Study (FHS;
n = 3052) were used to test, in multivariate-adjusted analyses, for association between serum urate and tomato intake.
Results: Seventy one percent of people with gout reported having ≥1 gout trigger food. Of these 20 % specifically
mentioned tomatoes, the 4th most commonly reported trigger food. There was association between tomato intake and
serum urate levels in the ARIC, CHS and FHS combined cohort (β = 0.66 μmolL−1 increase in serum urate per additional
serve per week; P = 0.006) - evident in both sexes (men: β = 0.84 μmolL−1, P = 0.035; women: β = 0.59 μmolL −1, P = 0.041).
Conclusions: While our descriptive and observational data are unable to support the claim that tomato consumption is a
trigger of gout attacks, the positive association between tomato consumption and serum urate levels suggests that the
self-reporting of tomatoes as a dietary trigger by people with gout has a biological basis.
Background
High serum urate levels are the major risk factor for
gout [1]. Urate levels are maintained within the body
through a balance between urate production (hepatic)
and excretion (renal and gut), controlled by genetic
and dietary factors [2]. When urate levels reach super-
saturation monosodium urate crystals may deposit
within the joints and elicit an immune reaction [3].
Variants in genes encoding renal and gut uric acid trans-
porters are associated with urate levels and gout [4–8],
while serum urate-controlling variants of weaker effect
map to loci thought to be involved in glycolysis and other
pathways enriched for inhibins and activins [5].
Foods and beverages positively associated with serum
urate and gout are alcohol (particularly beer), purine-rich
foods, red meat, seafood, and sugar-sweetened beverages
[9–15]. Conversely, intake of coffee, dairy products and
vitamin C have been associated with lowered serum urate
levels and reduced risk of gout [11, 16–20]. Urate is gener-
ated from breakdown of purines and as a consequence of
hepatic metabolism of alcohol and sugar, with evidence that
both ethanol and sugar also interfere with renal excretion
of uric acid [9, 21]. Gout is often associated with dietary
triggers, commonly perceived by patients to be the most
important cause of gout [22]. Demonstrated food triggers,
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identified using case-crossover study design, include
alcohol and purine-rich foods [23, 24]. These foods also
increase serum urate levels [12, 15, 25], consistent with
the hypothesis that they trigger acute gout attacks. People
with gout also self-report food avoidances that have not
been substantiated by the medical literature – these avoid-
ances include tomatoes and tomato products [26].
This study aimed to determine the frequency of to-
mato consumption as a self-reported trigger of gout
flares in a large gout sample set from New Zealand (in-
cluding Māori and Pacific Island participants). These
groups have a prevalence of gout double that of European
Caucasian [27], with earlier onset, more severe gout
presentation and a higher prevalence of co-morbidities
[28]. We also tested the hypothesis that tomato con-
sumption is associated with serum urate levels.
Methods
New Zealand men and women >17 years of age with
gout (n = 1791) (recruited as part of a study focused on
the risk factors for gout) [29] were asked the question
“Do certain foods/drinks trigger your gout?” Patients
were prompted to specify whether alcohol or seafood
triggered their gout, then given the opportunity to list
other gout trigger foods/drinks in an open-question
format. Responses to the same question by a separate
Māori sample set from the rohe (area) of the Ngati
Porou iwi (tribe), patients of the primary health care
provider Ngati Porou Hauora (health) Charitable Trust,
in the Tairawhiti region on the East Coast of the North
Island of New Zealand were also analysed (260 people
with gout). All participants had a confirmed diagnosis
of gout, as defined by the 1977 American Rheumatol-
ogy Association preliminary classification criteria for
acute gout [30]. They were recruited from community-
based settings, and primary and secondary health care.
Ethical approval was given by the New Zealand Multi-
Region and Northern Y Ethics Committees and all partici-
pants provided written informed consent for the collection
of samples and subsequent analysis. Anthropometric,
clinical and gout attack trigger information for each analysis
cohort are contained in Additional file 1: Table S1.
Trigger foods were summarised into ten categories
(alcohol, dairy products, fruit, poultry, red meat, seafood/
fish, sugar-sweetened beverages, tomatoes, vegetables, and
other) and the percentage of people who mentioned each
category calculated – split also into five ancestral groups,
New Zealand Māori, Ngati Porou Māori, New Zealand
Pacific Island, European and Other. Multivariate logistic
regression adjusted for sex, age at first attack, body mass
index, and number of flares per year was conducted to de-
termine whether ancestry influenced the reporting of
acute gout attack triggers.
Data from the Atherosclerosis Risk in Communities
(ARIC) (http://www2.cscc.unc.edu/aric/), Cardiovascu-
lar Health Study (CHS) (https://chs-nhlbi.org/) and
Framingham Heart Study (FHS) Generation 3 (http://
www.framinghamheartstudy.org/) cohorts were used to
test the hypothesis that tomato consumption is associ-
ated with serum urate levels. All three studies recruited
individuals from North America. Participants in these
studies completed a food frequency questionnaire that
asked “How often, on average, did you eat tomatoes or
tomato juice in the past year?” (Tomato sauce informa-
tion was also collected, but excluded for this analysis).
The questionnaire also asked about consumption of
seafood/fish (canned tuna fish, dark meat fish, shrimp,
lobster, scallops, and other fish), red meat (beef, pork,
lamb, bacon, processed meat, hamburgers, and hot-
dogs), alcohol (beer, wine, and liquor), sugar-sweetened
drinks (regular soft drink and non-carbonated fruit
drink), coffee (not decaffeinated) and dairy products
(milk, cream, butter, margarine, ice cream, cheese and
yoghurt). Vitamin C intake (mg/day) was also measured
in each of these studies. Study participants were asked
to answer these questions by choosing from food fre-
quency categories (9 categories in ARIC and FHS, with
1 indicating almost never, whilst 9 indicated ≥6 serves
per day; 6 categories in CHS, with 1 indicating never
whilst 6 indicated almost every day). These categorical
answers were converted to average serves per week for
analysis (Additional file 2: Table S2). Serum urate levels
(μmolL−1) were also measured at the time of data
collection (ARIC Visit 1: 1987–1989; uricase oxidation
method [31]; CHS Baseline collection: 1989–1990;
measured with a Kodak Ektachem 700 analyser with
reagents [32]; FHS Generation 3 Exam 1: 2002–2005,
auto-analysed with a phosphotungstic acid reagent [33]).
European sample sets for analysis were developed for
each of the ARIC, FHS and CHS data sets following
consistent exclusion criteria between groups (Additional
file 3: Figure S1). People without serum urate measure-
ments or genome-wide genotyping were excluded along
with non-European individuals and individuals with
kidney disease, established gout, taking urate-lowering
drugs, or on diuretic medication. Quality controls for
the food frequency data were also used, with individ-
uals who answered less than 10 % of the food fre-
quency survey excluded, along with individuals whose
average daily calorie intake was less than 600 kcal/day
and greater than 4200 kcal/day. This left 12,720 indi-
viduals for analysis (ARIC: 7517, 52 % female, age
range 44–65; CHS: 2151, 59 % female, age range 64–
97; and FHS: 3052, 54 % female, age range 19–72). An-
thropometric, clinical and dietary information for each
analysis cohort are contained in Additional file 4:
Table S3.
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Multivariate linear regression adjusted for common
risk factors (sex, age, body mass index and menopausal
status), whole-genome principal component analysis vec-
tors 1 and 2 (PCA1 and PCA2) and average daily calorie
intake (kcal/day), along with other known dietary trig-
gers, was conducted and the results for the separate
ARIC, CHS and FHS sample sets combined by inverse-
variance weighted meta-analysis. The ARIC, CHS and
FHS cohorts were further divided into male only (ARIC:
3614, CHS: 877, FHS: 1394) and female only (ARIC:
3903, CHS: 1274, FHS: 1658) subsets, on which multi-
variate linear regression adjusted for age, body mass
index, PCA1, PCA2 and calorie intake (and menopausal
status in the women only subsets) was performed and
the sample sets again combined by meta-analysis. Multi-
variate linear regression between serum urate levels and
each of the known dietary trigger foods (using the same
adjustments as stated previously) was also performed for
all individuals and the male and female only subsets
(Additional file 5: Table S4). All statistical analysis was
performed using R v3.0.2 (http://www.R-project.org/).
Meta-analysis using an inverse-variance fixed effect model
was performed using the R package “meta 3.1-1” (http://
cran.r-project.org/web/packages/meta/).
Results
Of the 2051 New Zealand men and women with gout
who were surveyed, 1447 (70.6 %) self-reported ≥1 food
or drink trigger of acute gout attacks; 905 (62.5 %) spe-
cified seafood or fish, 681 (47.1 %) alcohol, 509 (35.2 %)
red meat and 292 (20.2 %) tomatoes (Fig. 1); with
69.4 % specifying >1 trigger. Vegetables, fruit and sugar-
sweetened drinks ranked fifth, sixth, and seventh most
common reported trigger foods, respectively. Triggers
were more commonly reported in New Zealand Māori,
Ngati Porou Māori and New Zealand Pacific Island people
than European (76.2, 79.1, 88.3 and 57.8 %, respectively).
Compared to European, after adjusting for factors influen-
cing the severity of gout, New Zealand Pacific Island
people were 3.87-fold (95 % confidence interval (2.72 to
5.61), P = 1.9x10−13), New Zealand Māori 1.91-fold ((1.38
to 2.68), P = 1.3x10−4) and Ngati Porou Māori 3.00-fold
((1.98 to 4.66), P = 4.7x10−7) more likely to self-report a
trigger of gout attacks. Similarly Pacific Island people,
New Zealand Māori and Ngati Porou Māori were more
likely to self-report tomatoes as a trigger of gout flares
(1.48-fold ((1.02 to 2.18), P = 0.04); 1.98-fold ((1.32 to
2.97), P = 8.8x10−4); 2.58-fold ((1.69 to 3.93), P = 1.0x10−5),
respectively) than those of European descent.
The three most commonly mentioned dietary triggers
of gout have been positively correlated with serum urate
levels [12, 15, 25]. Therefore we hypothesised that toma-
toes, the fourth most common self-reported trigger of
gout flares in New Zealand, also increase serum urate
levels. We tested for association between tomato con-
sumption and serum urate in the ARIC, CHS and FHS
European Caucasian sample sets. A positive association
was observed in the ARIC sample set (β = 0.91 μmolL−1
increase in serum urate per additional serve per week of
tomatoes, P = 0.006) with a positive direction in CHS
and FHS (β = 0.22 μmolL−1, P = 0.79 and β = 0.43
μmolL−1, P = 0.27 respectively). There was positive
Fig. 1 Frequency at which 1447 individuals (478 European, 256 New Zealand Māori, 197 Ngati Porou Māori, 421 Pacific Island, 95 Other ethnicity)
who reported ≥1 food trigger of gout flares, specified each food type/category
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association in the combined samples (β = 0.66 μmolL−1,
P = 0.006) (Table 1). The association was also seen in
both the men only and women only sub-sets, with a
larger effect size in the men only group (men: β = 0.84
μmolL−1, P = 0.035; women: β = 0.59 μmolL−1, P = 0.041)
(Table 1).
The association between tomato consumption and
serum urate levels was maintained after adjustment for
other accepted food triggers, both in a univariate model
(red meat: β = 0.69 μmolL−1 per additional serving of
tomatoes per week, P = 0.008; seafood/fish: β = 0.58
μmolL−1, P = 0.029; sugar-sweetened soft drinks/juices:
β = 0.72 μmolL−1, P = 0.006; dairy products: β = 0.60
μmolL−1, P = 0.019; coffee: β = 0.67 μmolL−1, P = 0.011;
vitamin C: β = 0.78 μmolL−1, P = 0.004; alcohol: β = 0.53
μmolL−1, P = 0.024), and a multivariate model (β = 0.66
μmolL−1, P = 0.008) (Table 2). Data from the separate
sample sets are presented in Additional file 5: Table S4.
The nutritional exposure data for the specific food
items used in this study have previously been validated
for the separate ARIC, CHS and FHS cohorts [34–37].
To empirically investigate the validity of the nutritional
exposure data we tested four specific foods accepted as
urate-raising and conferring of risk of gout (red meat,
seafood/fish, sugar-sweetened beverages, alcohol) [9–13]
and one urate-lowering and gout protective (dairy
products) [11, 12]. Each of these foods was associated
with urate, in the expected direction, in either the com-
bined (seafood/fish, dairy products, alcohol) or sex-
specific (red-meat, sugar-sweetened beverages) analysis
(Additional file 6: Table S5).
Discussion
Tomatoes are the fourth most common self-reported
trigger of gout attacks in a New Zealand sample set.
New Zealand Pacific Island, New Zealand Māori and
Ngati Porou Māori people were more likely to self-
report a trigger of gout flares than European Caucasian
(3.87, 1.91 and 3.00-fold, respectively). This was inde-
pendent of indicators of severity, including number of
acute attacks per year. It is possible that self-recognition
of attack triggers is a reflection of a greater community
familiarity with gout due to a higher prevalence and
longer disease history in Pacific Island and Māori popula-
tions, with evidence for gout in these populations pre-
Westernisation [38, 39]. Tomato has also previously been
reported as a food avoided by Australian gout patients,
with the authors noting that the current evidence does
not support this avoidance [26].
Here we provide evidence that tomato consumption
is positively associated with serum urate in European
Caucasians suggesting that the avoidance of tomatoes
by gout patients (due to identification as triggers of acute
gout attacks) is not an unfounded practice. Whilst our
data cannot support the claim that tomato consumption
is a trigger of gout attacks we provide support for the
hypothesis that tomato consumption may trigger gout
attacks through increasing serum urate. In order to assess
the clinical relevance of these data it is useful to compare
the increase in serum urate attributed to a one serve per
week increase in tomato consumption (0.7 μmolL−1) with
other recognised gout attack trigger foods that also in-
crease serum urate (men and women combined). Alcohol
increased serum urate by 2.3 μmolL−1 per serving per week
in the United States third National Health and Nutrition
Examination Survey (NHANES) [25]. In the ARIC sample
set sugar-sweetened drinks increased urate 0.4 μmolL−1
per serve per week [9], and in the third NHANES sample
set total meat and seafood increased urate 0.5 μmolL−1 and
2.4 μmolL−1 per extra serve per week, respectively [12].
Thus tomatoes alter serum urate levels to an extent com-
parable to other established dietary risk factors for gout.
To assess the causal influence of tomatoes on serum
urate levels intervention studies need to be conducted.
Small studies investigating the influence of tomatoes or
tomato products on other biomarkers have been con-
ducted, with several measuring urate levels before and
after intervention took place (Table 3) [40–46]. Lee et al.
[43] found an average increase of 46 μmolL−1 (P < 0.05)
in plasma urate levels in a small cohort of young Chin-
ese men (n = 10, 26 ± 1 years) 48 h after consumption of
150 g tomato sauce [43]. Conversely a recent study by
Table 1 Association between serum urate levels (μmolL−1) and tomato consumption (serves/week)
All1 Men Women2
β (95 % CI) P β (95 % CI) P β (95 % CI) P
ARIC 0.907 (0.264; 1.550) 0.006 1.399 (0.392; 2.405) 0.006 0.488 ( −0.335; 1.310) 0.245
CHS 0.216 ( −1.341; 1.772) 0.786 1.163 ( −1.578; 3.903) 0.406 −0.279 ( −2.144; 1.586) 0.769
FHS 0.428 ( −0.337; 1.193) 0.273 −0.289 ( −1.665; 1.087) 0.680 0.893 (0.030; 1.757) 0.043
Combined3 0.664 (0.194; 1.133) 0.006 0.839 (0.060; 1.618) 0.035 0.592 (0.024; 1.159) 0.041
Adjusted for age, BMI, average calorie intake (kcal/day) and PCA vectors 1 and 2
P-value: All = 0.540, Men = 0.148 and Women = 0.505, respectively
1Also adjusted for sex and menopause status
2Also adjusted for menopause status
3Heterozygosity
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Vinha et al. [46] found an average drop of 10 μmolL−1 in
plasma urate levels (P < 0.05) in a cohort of young
women (n = 35, 19.6 ± 1.3 years) who ingested a ~90 g
tomato before their midday meal for 30 consecutive
days. Four additional intervention studies were unable
to find any significant difference in serum or plasma
urate levels after intervention [40, 41, 44, 45]. Similarly
Jacob et al. [43] found no significant difference in the
plasma urate levels of 12 individuals (23 ± 2 years) after
consumption of 500 mL tomato juice per day for
2 weeks, however an increase in renal urate clearance
(urate:creatinine ratio) was observed in these individ-
uals (P < 0.05). Only the study conducted by Vinha et
al. [46] used whole tomato fruit as the intervention
product, more commonly tomato juice or sauce was
used in these studies. This creates the possibility that
other additives or the concentrated nature or the pro-
cessing (eg production and loss of urate-influencing
chemicals) of these products influence urate levels,
such as sugars (2-3 % content) or added vitamin C (0-4 %
content). Generally, the demographics of the groups stud-
ied (Table 3) are different (younger) to the group in which
we associated tomato consumption with serum urate
levels (Additional file 4: Table S3). In the case of Vinha et
al. [46] their conclusion that the changes in biochemical
and anthropometric parameters may be due to a decrease
in postprandial hunger suggests the decrease in plasma
urate levels observed could be due to a decrease in con-
sumption of other serum urate-raising foods between
meals rather than solely the function of tomato consump-
tion itself. The influence of other serum urate-raising
foods was accounted for in our analysis.
The association we have seen between tomatoes and
serum urate supports the hypothesis of a possible effect of
tomatoes on either hepatic urate production or renal uric
acid handling. Any effect of tomatoes on renal uric acid
excretion could be mediated by phenolic acid. The
inhibitory effects of nine phenolic acid compounds on
three renally expressed organic anion transporters (OAT1,
OAT3, and OAT4) have been tested [47], all of which
transport uric acid [48]. All compounds modified the
capability of OAT1 and OAT3 to transport endogenous
substrates in vitro, whilst two compounds (syringic acid
and sinapinic acid) weakly affected OAT4 [47]. Some of
the OAT1/OAT3 interacting compounds (p-coumaric
acid, ferullic acid, p-hydroxybenzoic acid and vanillic acid)
are present in tomatoes [49]. Of these three transporters,
only OAT4 (encoded by SLC22A11) has been genetically
associated with serum urate and gout [4, 5, 8, 29].
Alternatively tomatoes may be influencing urate levels
through increased production. Urate is the end product
of purine break-down in humans, and consumption of
foods with a high purine-content (red meats, seafood,
beer) results in raised serum urate levels and risk of gout
[10–12, 25]. Tomatoes, however, have a very low purine-
content [50]. Instead tomatoes contain high levels of
glutamate, an amino acid which is often found in foods
with a high purine-content and is able to stimulate or
amplify the synthesis of urate by acting as a nitrogen
donor in the purine synthesis pathway [50, 51].
How an increase in serum urate levels could cause an
attack of gout is currently not resolved. Intra-articular
injection of urate does not induce inflammatory arthritis
as compared to monosodium urate (MSU) crystal injec-
tion [52] and a well-established trigger of gout attacks is
a decrease in urate, for example from initiation of urate-
lowering therapy, believed to be caused by crystal shed-
ding in the joint. However, all established dietary triggers
of gout flares are characterised by a positive association
between consumption and serum urate [12, 15, 25], sug-
gesting that dietary-induced increases in serum urate are
important in gout attacks. Given, however, that MSU
nucleation and crystal growth is slow compared to dis-
solution [53] it is possible that the observed dietary-
Table 2 Association between serum urate levels (μmolL−1) and tomato consumption (serves/week) adjusted for consumption of
known serum urate influencing foods in the meta-analysis combined cohort
All1 Men Women2
Adjusted by β (95 % CI) P Het P β (95 % CI) P Het P β (95 % CI) P Het P
Red Meat 0.689 (0.177; 1.202) 0.008 0.607 0.855 ( −0.030; 1.740) 0.058 0.260 0.633 (0.030; 1.235) 0.040 0.726
Seafood/Fish 0.575 (0.060; 1.091) 0.029 0.485 0.765 ( −0.125; 1.655) 0.092 0.271 0.467 ( −0.139; 1.073) 0.131 0.637
Sugar −Sweetened Beverages 0.719 (0.207; 1.231) 0.006 0.459 0.909 (0.026; 1.792) 0.044 0.225 0.619 (0.017; 1.222) 0.044 0.593
Dairy Products 0.613 (0.102; 1.124) 0.019 0.600 0.689 ( −0.193; 1.572) 0.126 0.345 0.566 ( −0.035; 1.167) 0.065 0.611
Coffee 0.667 (0.154; 1.180) 0.011 0.544 0.854 ( −0.032; 1.740) 0.059 0.262 0.575 ( −0.027; 1.177) 0.061 0.564
Vitamin C 0.776 (0.253; 1.300) 0.004 0.570 0.889 ( −0.004; 1.782) 0.051 0.284 0.743 (0.124; 1.362) 0.019 0.797
Alcohol 0.534 (0.069; 1.000) 0.024 0.527 0.657 ( −0.114; 1.428) 0.095 0.089 0.468 ( −0.096; 1.032) 0.104 0.487
All Urate Influencing Foods 0.655 (0.173; 1.136) 0.008 0.332 0.665 ( −0.124; 1.45) 0.099 0.105 0.632 (0.045; 1.219) 0.035 0.779
Adjusted for age, BMI, average calorie intake (kcal/day) and PCA vectors 1 and 2
1Also adjusted for sex and menopause status
2Also adjusted for menopause status
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Table 3 Summary information for seven tomato intervention studies that measured urate levels before and after intervention
Study Total (n) Age1 (years) Urate Measurement Start Urate2
(μmolL-1)
End Urate2
(μmolL-1)
P-value3 Intervention
All M F
Engelhard et al. (37)4 31 18 13 48 (30–73) Serum 336.7 ± 14.3 349.2 ± 15.5 P > 0.05 Participants consumed 1 250 mg ‘Lyc-O-Mato’
tomato extract capsule per day for 8 weeks
Jacob et al. (38) 24 4 20 23 (19–27) Plasma 221.4 ± 49.8 221.0 ± 45.9 P > 0.05 Participants consumed 250 mL tomato
juice twice daily for 2 weeks5
Urinary (mg/mg Cr) 0.39 ± 0.2 0.52 ± 0.2 P < 0.05
Lee et al. (39)6 10 10 - 26 Plasma 348 ± 55 394 ± 407 P < 0.01 Participants consumed a single 150 g portion
of tomato sauce
Todd et al. (40)4,8 34 13 21 52 (27–64) Plasma 326.1 ± 73.9 329.1 ± 77.5 P > 0.05 Participants consumed 500 mL tomato
juice per day for 4 weeks
Todd et al. (41)8 23 5 18 44 (24–61) Plasma 280.5 ± 72.0 292.2 ± 67.0 P > 0.05 Participants consumed 500 mL tomato juice
per day for 4 weeks
Abete et al. (36) 30 18 12 (18–50) Serum 267.7 ± 53.5 261.7 ± 71.4 P > 0.05 Participants consumed 160 g tomato
sauce per day for 4 weeks
Vinha et al. (42) 35 - 35 20 (18–25) Plasma 207.6 ± 55.9 198.1 ± 46.4 P < 0.001 Participants consumed an ~90 g tomato each
day before lunch for 4 weeks
1Average (range)
2Average ± standard deviation
3All P-values were obtained using a Paired Student’s t-test or one-way ANOVA to assess data for significant changes before and after intervention (P < 0.05 indicates significance)
4All participants had hypertension
5Participants were divided into two groups – data are shown for only 12 individuals (no demographic data were available)
6All participants were of Chinese ethnicity
7Measurement taken 48 h after tomato consumption
8All uric acid data was not published, data shown here was provided by the study authors directly
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associations with serum urate may require other factors
to induce acute gout attacks, for example an increase in
free-fatty acids that could be within or induced by the
trigger food [54].
To our knowledge this is the first time tomatoes have
been associated with serum urate, suggesting that the
avoidance of tomatoes by people with gout may have a
biological basis. Further research into the relationship
between gout (and onset of gout attacks) and tomatoes
needs to be conducted, to further investigate this rela-
tionship, potentially with a case-crossover study design,
as previously used to demonstrate a purine-rich diet and
alcohol as triggers of acute gout attacks [22, 24]. Ana-
lysis of any effect on urinary uric acid excretion and
glutamate metabolism is also required to identify the
mechanisms behind this association.
Conclusion
The positive association between tomato consumption
and serum urate levels supports the hypothesis that the
self-reporting of tomatoes as a dietary trigger by people
with gout has a biological basis.
Additional files
Additional file 1: Table S1. Characteristics of New Zealand gout study
samples. (DOC 65 kb)
Additional file 2: Table S2. ARIC, CHS and FHS food frequency
questionnaire answer categories and conversion to serves/week.
(DOC 37 kb)
Additional file 3: Figure S1. Schematic of exclusions for the
Atherosclerosis Risk in Communities (ARIC), Cardiovascular Health Study
(CHS) and Framingham Heart Study (FHS). (DOC 132 kb)
Additional file 4: Table S3. Characteristics of publically-available European
study samples. (DOC 57 kb)
Additional file 5: Table S4. Association between serum urate levels
(μmolL −1) and tomato consumption (serves/week) adjusted for
consumption of known serum urate influencing foods in the ARIC, CHS
and FHS cohorts. (DOC 71 kb)
Additional file 6: Table S5. Association between serum urate levels
(μmolL −1) and consumption of five established urate influencing foods
(serves/week) in the ARIC, CHS, FHS and combined cohorts. (DOC 66 kb)
Abbreviations
ARIC: Atherosclerosis Risk in Communities; CHS: Cardiovascular Health Study;
FHS: Framingham Heart Study; MSU: Monosodium urate; NHANES: National
Health and Nutrition Examination Survey; OAT: Organic anion transporter;
PCA: Principal component analysis; SLC: Solute carrier.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TJF, RT and TRM helped to design the study, oversee its execution, and
prepare the manuscript. ND, PBJ, LKS and JHH helped to provide clinical
recruitment and prepare the manuscript. AST and RJW provided data and
helped prepare the manuscript. MC helped to analyze data and prepare the
manuscript. All authors read and approved the final manuscript.
Acknowledgements
The New Zealand Health Research Council, Lottery Health New Zealand,
Arthritis New Zealand and the University of Otago are thanked for funding
this study. Ria Akuhata, Nancy Aupouri (Ngati Porou Hauora), Jill Drake
(Canterbury District Health Board), Roddi Laurence (University of Auckland)
and Gabrielle Sexton are thanked for assistance in recruitment. The authors
sincerely thank all participants with gout who donated time and information
for this study. The Atherosclerosis Risk in Communities Study is carried out as
a collaborative study supported by the National Heart, Lung and Blood
Institute (NHLBI) contracts N01-HC-55015, N01 HC-55016, N01-HC-55018,
N01-HC- 55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, R01 HL087641,
R01 HL59367, and R01 HL086694; National Human Genome Research Institute
contract U01HG004402; and National Institutes of Health (NIH) contract
HHSN268200625226C. The CHS research reported in this article was supported
by contract numbers N01-HC-85079, N01-HC-85080, N01-HC-85081, N01-
HC-85082, N01-HC-85083, N01-HC-85084, N01-HC-85085, N01-HC-85086,
N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-
45133, N01-HC-85239 and HHSN268201200036C; grant numbers U01
HL080295 from the National Heart, Lung, and Blood Institute and R01 AG-
023629 from the National Institute on Aging, with additional contribution
from the National Institute of Neurological Disorders and Stroke. A full list
of principal CHS investigators and institutions can be found at http://
www.chs-nhlbi.org/pi. The Framingham Heart Study is supported by NHLBI
contract N01-HC-25195. This article was not prepared in collaboration with inves-
tigators of the Atherosclerosis Risk in Communities Study, Cardiovascular Health
Study or Framingham Heart Study and does not necessarily reflect the opinions
or views of these studies, or the NHLBI. The authors thank the staff and partici-
pants of the ARIC, CHS and FHS studies for their important contributions.
Author details
1Department of Biochemistry, University of Otago, Box 56, Dunedin, New
Zealand. 2Department of Medicine, University of Auckland, Auckland, New
Zealand. 3Department of Medicine, University of Otago, Christchurch, New
Zealand. 4Ngati Porou Hauora Charitable Trust, Te Puia Springs, New Zealand.
5Mater Research Institute, Brisbane, Australia and School of Allied Health Sciences,
Griffith University, Gold Coast, Australia. 6Department of Medicine, University of
Otago, Dunedin, New Zealand.
Received: 20 December 2014 Accepted: 4 August 2015
References
1. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and
consequences in the Normative Aging Study. Am J Med. 1987;82:421–6.
2. Robinson PC, Horsburgh S. Gout: Joints and beyond, epidemiology, clinical
features, treatment and co-morbidities. Maturitas. 2014;78:245–51.
3. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated
uric acid crystals activate the NALP3 inflammasome. Nature.
2006;440:237–41.
4. Phipps-Green A, Merriman M, Topless R, Altaf S, Montgomery GW, Franklin C,
Jones GT, van Rij AM, White D, Stamp LK, Dalbeth N, Merriman TR: Twenty-
eight loci that influence serum urate levels: analysis of association with gout.
Ann Rheum Dis 2014, Sep 3. pii: annrheumdis-2014-205877.
doi: 10.1136/annrheumdis-2014-205877. (Epub ahead of print)
5. Köttgen A, Albrecht E, Teumer A, Vitart V, Krumsiek J, Hundertmark C, et al.
Genome-wide association analyses identify 18 new loci associated with
serum urate concentrations. Nat Genet. 2013;45:145–54.
6. Merriman TR, Choi HK, Dalbeth N. The genetic basis of gout. Rheum Dis
Clin North Am. 2014;40:279–90.
7. Merriman TR. Population heterogeneity in the genetic control of serum
urate. Semin Nephrol. 2011;31:420–5.
8. Urano W, Taniguchi A, Inoue E, Sekita C, Ichikawa N, Koseki Y, et al. Effect of
genetic polymorphisms on development of gout. J Rheumatol.
2013;40:1374–8.
9. Batt C, Phipps-Green A, Black MA, Cadzow M, Merriman ME, Topless R, et al.
Sugar-sweetened beverage consumption: a risk factor for prevalent gout
that interacts with SLC2A9 genotype-specific effects on serum urate and
risk of gout. Ann Rheum Dis. 2014;73:2101–6.
10. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and
risk of incident gout in men: a prospective study. Lancet. 2004;363:1277–81.
Flynn et al. BMC Musculoskeletal Disorders  (2015) 16:196 Page 7 of 8
11. Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods,
dairy and protein intake, and the risk of gout in men. N Engl J Med.
2004;350:1093–103.
12. Choi HK, Liu S, Curhan G. Intake of purine-rich foods, protein, and dairy
products and relationship to serum levels of uric acid: The Third National
Health and Nutrition Examination Survey. Arthritis Rheum. 2005;52:283–9.
13. Choi HK, Willett W, Curhan G. Fructose-rich beverages and risk of gout in
women. JAMA. 2010;304:2270–8.
14. Hak AE, Choi H. Menopause, postmenopausal hormone use and serum uric
acid levels in US women - The Third National Health and Nutrition
Examination Survey. Arthritis Res Ther. 2008;10:R116.
15. Rasheed H, Phipps-Green A, Topless R, Hollis-Moffatt JE, Hindmarsh JH,
Franklin C, et al. Association of the lipoprotein receptor-related protein 2
gene with gout and non-additive interaction with alcohol consumption.
Arthritis Res Ther. 2013;15:R177.
16. Choi HK, Curhan G. Coffee consumption and risk of incident gout in
women: the Nurses' Health Study. Am J Clin Nutr. 2010;92:922–7.
17. Choi HK, Curhan G. Coffee, tea, and caffeine consumption and serum uric
acid level: the third national health and nutrition examination survey.
Arthritis Rheum. 2007;57:816–21.
18. Choi HK, Gao X, Curhan G. Vitamin c intake and the risk of gout in men: A
prospective study. Arch Intern Med. 2009;169:502–7.
19. Choi HK, Willett W, Curhan G. Coffee consumption and risk of incident gout
in men: a prospective study. Arthritis Rheum. 2007;56:2049–55.
20. Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, et al. The
effects of vitamin C supplementation on serum concentrations of uric acid:
results of a randomized controlled trial. Arthritis Rheum. 2005;52:1843–7.
21. Lieber CS, Jones DP, Losowsky MS, Davidson CS. Interrelation of uric acid
and ethanol metabolism in man. J Clin Invest. 1962;41:1863–70.
22. Dalbeth N, Petrie KJ, House M, Chong J, Leung W, Chegudi R, et al. Illness
perceptions in patients with gout and the relationship with progression of
musculoskeletal disability. Arthritis Care Res. 2011;63:1605–12.
23. Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, et al. Purine-rich
foods intake and recurrent gout attacks. Ann Rheum Dis. 2012;71:1448–53.
24. Zhang Y, Woods R, Chaisson CE, Neogi T, Niu J, McAlindon TE, et al.
Alcohol consumption as a trigger of recurrent gout attacks. Am J Med.
2006;119:e13–18.
25. Choi HK, Curhan G. Beer, liquor, and wine consumption and serum uric acid
level: The Third National Health and Nutrition Examination Survey. Arthritis
Care Res. 2004;51:1023–9.
26. Shulten P, Thomas J, Miller M, Smith M, Ahern M. The role of diet in the
management of gout: a comparison of knowledge and attitudes to current
evidence. J Hum Nutr Diet. 2009;22:3–11.
27. Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Arroll B, et al. National
prevalence of gout derived from administrative health data in Aotearoa
New Zealand. Rheumatology (Oxford). 2012;51:901–9.
28. Hollis-Moffatt JE, Phipps-Green AJ, Chapman B, Jones GT, van Rij A, Gow P,
et al. The renal urate transporter SLC17A1 locus: confirmation of association
with gout. Arthritis Res Ther. 2012;14:R92. doi:10.1186/ar3816.
29. Flynn T, Phipps-Green A, Hollis-Moffatt JE, Merriman ME, Topless R,
Montgomery GW, et al. Association analysis of the SLC22A11 (organic anion
transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus
with gout in New Zealand case–control sample sets reveals multiple
ancestral-specific effects. Arthritis Res Ther. 2013;15:R220.
30. Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary
criteria for the classification of the acute arthritis of primary gout. Arthritis
Rheum. 1977;20:895–900.
31. Investigators ARIC. The Atherosclerosis Risk in Communities (ARIC) Study:
design and objectives. Am J Epidemiol. 1989;129:687–702.
32. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP. Laboratory methods
and quality assurance in the Cardiovascular Health Study. Clin Chem.
1995;41:264–70.
33. Crowley LV. Determination of uric acid an automated analysis based on a
carbonate method. Clin Chem. 1964;10:838–44.
34. Kumanyika S, Tell GS, Fried L, Martel JK, Chinchilli VM. Picture-sort method
for administering a food frequency questionnaire to older adults.
J Am Diet Assoc. 1996;96:137–44.
35. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC.
Reproducibility and validity of an expanded self-administered semiquantitative
food frequency questionnaire among male health professionals.
Am J Epidemiol. 1992;135:1114–26.
36. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, et al.
Reproducibility and validity of a semiquantitative food frequency
questionnaire. Am J Epidemiol. 1985;122:51–65.
37. Stevens J, Metcalf PA, Dennis BH, Tell GS, Shimakawa T, Folsom AR.
Reliability of a food frequency questionnaire by ethnicity, gender, age and
education. Nutr Res. 1996;16:735–45.
38. Buckley H. Epidemiology of Gout: Perspectives from the Past. Curr Rheum
Rev. 2011;7:106–13.
39. Gosling AL, Matisoo-Smith E, Merriman TR. Gout in Māori: Modern affliction
or ancestral trait? Rheumatology (Oxford). 2014;53:773–4.
40. Abete I, Perez-Cornago A, Navas-Carretero S, Bondia-Pons I, Zulet MA,
Martinez JA. A regular lycopene enriched tomato sauce consumption
influences antioxidant status of healthy young subjects: A crossover study.
J Func Foods. 2013;5:28–35.
41. Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract
reduce blood pressure in patients with grade-1 hypertension: A double-
blind, placebo-controlled pilot study. Am Heart J. 2006;151:100.
42. Jacob K, Periago MJ, Bohm V, Berruezo GR. Influence of lycopene and
vitamin C from tomato juice on biomarkers of oxidative stress and
inflammation. Br J Nutr. 2008;99:137–46.
43. Lee C-YJ, Isaac HB, Huang SH, Long LH, Wang H, Gruber J, et al. Limited
antioxidant effect after consumption of a single dose of tomato sauce by
young males, despite a rise in plasma lycopene. Free Radic Res.
2009;43:622–8.
44. Todd AS, Macginley RJ, Schollum JB, Johnson RJ, Williams SM, Sutherland
WH, et al. Dietary salt loading impairs arterial vascular reactivity. Am J Clin
Nutr. 2010;91:557–64.
45. Todd AS, Macginley RJ, Schollum JB, Williams SM, Sutherland WH, Mann JI,
et al. Dietary sodium loading in normotensive healthy volunteers does not
increase arterial vascular reactivity or blood pressure. Nephrology.
2012;17:249–56.
46. Vinha AF, Barreira SV, Costa AS, Alves RC, Oliveira MB. Pre-meal tomato
(Lycopersicon esculentum) intake can have anti-obesity effects in young
women? Int J Food Sci Nutr. 2014;65:1019–26.
47. Wang L, Sweet DH. Potential for food-drug interactions by dietary phenolic
acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4
(SLC22A11). Biochem Pharmacol. 2012;84:1088–95.
48. Anzai N, Endou H. Urate transporters: an evolving field. Semin Nephrol.
2011;31:400–9.
49. Mattila P, Kumpulainen J. Determination of free and total phenolic acids in
plant-derived foods by HPLC with diode-array detection. J Ag Food Chem.
2002;50:3660–7.
50. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Lanaspa MA, Tamura Y,
Tanabe K, et al. Umami: the taste that drives purine intake. J Rheumatol.
2013;40:1794–6.
51. Raivio KO, Seegmiller JE. Role of glutamine in purine synthesis and in
guanine nucleotide formation in normal fibroblasts and in fibroblasts
deficient in hypoxanthine phosphoribosyltransferase activity. Biochim Biophysic
Acta. 1973;299:283–92.
52. McCarty JDJ. Mechanisms of the crystal deposition diseases - gout and
pseudogout. Ann Intern Med. 1973;78:767–71.
53. Erwin CL, Nancollas GH. The crystallization and dissolution of sodium urate.
J Crystal Growth. 1981;53:215–23.
54. Joosten LA, Netea MG, Mylona E, Koenders MI, Malireddi RK, Oosting M, et al.
Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β
production via the ASC/caspase 1 pathway in monosodium urate
monohydrate crystal-induced gouty arthritis. Arthritis Rheum.
2010;62:3237–48.
Flynn et al. BMC Musculoskeletal Disorders  (2015) 16:196 Page 8 of 8
